FFRFT - Overview: Anti-Synthetase Profile
Anti-Synthetase Profile
APTSC - Overview: Activated Partial Thromboplastin Time (APTT), Plasma
Screening for certain coagulation factor deficiencies and abnormalities (eg, factor VIII, IX, XI, or XII) Detecting coagulation inhibitors such as lupus anticoagulant, antiphospholipid antibodies, specific factor inhibitors, and...
SBULB - Overview: Spinobulbar Muscular Atrophy (Kennedy Disease), Molecular Analysis, Varies
Molecular confirmation of clinically suspected cases of sporadic or familial spinobulbar muscular atrophy (SBMA) Presymptomatic testing for individuals with a family history of SBMA and a documented expansion in the androgen receptor (AR)...
TGABI - Overview: Thyroglobulin Antibody, Serum
Initial testing as a part of evaluating suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result
SGSU - Overview: Synthetic Glucocorticoid Screen, Random, Urine
Confirming the presence of the listed synthetic glucocorticoids Confirming the cause of secondary adrenal insufficiency
LPCBS - Overview: Lysophosphatidylcholines, LC MS/MS, Blood Spot
Second-tier newborn screen for X-linked adrenoleukodystrophy This test is not intended for metabolic screening of symptomatic patients. This test is supplemental and not intended to replace state mandated newborn screening.
SLEG - Overview: Legionella pneumophila (Legionnaires Disease), Antibody, Serum
Evaluating possible legionellosis (Legionnaires disease, Pontiac fever, extrapulmonary legionella infection caused by Legionella pneumophila)
GATOL - Overview: Galactitol, Quantitative, Urine
Monitoring effectiveness of treatment in patients with galactosemia Establishing a baseline level prior to initiating treatment for galactosemia
F_10 - Overview: Coagulation Factor X Activity Assay, Plasma
Diagnosing deficiency of coagulation factor X, congenital or acquired Evaluating hemostatic function in liver disease Investigation of prolonged prothrombin time or activated partial thromboplastin time
HCCGS - Overview: Hepatocellular Carcinoma Risk Panel with GALAD Score, Serum
Risk assessment for development of hepatocellular carcinoma in patients with chronic liver disease